SEC Form SC 13G filed by Rockley Photonics Holdings Limited

$RKLY
Semiconductors
Technology
Get the next $RKLY alert in real time by email
SC 13G 1 formsc13g.htm

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13G

 

Under the Securities Exchange Act of 1934

 

Rockley Photonics Holdings Limited

 

(Name of Issuer)

 

Ordinary Shares, $0.000004026575398 par value per share

 

(Title of Class of Securities)

 

G7614L109

 

(CUSIP Number)

 

May 27, 2022

 

(Date of Event which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

☐ Rule 13d-1(b)

☒ Rule 13d-1(c)

☐ Rule 13d-1(d)

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

 
 

 

CUSIP No. G7614L109

 

1.

NAMES OF REPORTING PERSONS

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

 

ROC SPV XIX LLC

2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(see instructions)

(a) ☐

(b) ☒

3.

SEC USE ONLY

 

4.

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON WITH

5.

SOLE VOTING POWER

 

0

6.

SHARED VOTING POWER

 

11,500,000*

7.

SOLE DISPOSITIVE POWER

 

0

8.

SHARED DISPOSITIVE POWER

 

11,500,000*

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

11,500,000*

10.

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

 

(see instructions) ☐

11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

8.2%*

12.

TYPE OF REPORTING PERSON (see instructions)

 

OO

 

 
 

 

CUSIP No. G7614L109

 

1.

NAMES OF REPORTING PERSONS

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

 

ATW Partners Opportunities Management, LLC

2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(see instructions)

(a) ☐

(b) ☒

3.

SEC USE ONLY

 

4.

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON WITH

5.

SOLE VOTING POWER

 

0

6.

SHARED VOTING POWER

 

13,917,571*

7.

SOLE DISPOSITIVE POWER

 

0

8.

SHARED DISPOSITIVE POWER

 

13,917,571*

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

13,917,571*

10.

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

 

(see instructions) ☐

11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

9.9%*

12.

TYPE OF REPORTING PERSON (see instructions)

 

IA, OO

 

 
 

 

CUSIP No. G7614L109

 

1.

NAMES OF REPORTING PERSONS

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

 

Antonio Ruiz-Gimenez

2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(see instructions)

(a) ☐

(b) ☒

3.

SEC USE ONLY

 

4.

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Spain

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5.

SOLE VOTING POWER

 

0

6.

SHARED VOTING POWER

 

13,917,571*

7.

SOLE DISPOSITIVE POWER

 

0

8.

SHARED DISPOSITIVE POWER

 

13,917,571*

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

13,917,571*

10.

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

 

(see instructions) ☐

11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

9.9%*

12.

TYPE OF REPORTING PERSON (see instructions)

 

IN, HC

 

 
 

 

CUSIP No. G7614L109

 

1.

NAMES OF REPORTING PERSONS

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

 

Kerry Propper

2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(see instructions)

(a) ☐

(b) ☒

3.

SEC USE ONLY

 

4.

CITIZENSHIP OR PLACE OF ORGANIZATION

 

United States

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5.

SOLE VOTING POWER

 

35,000

6.

SHARED VOTING POWER

 

13,917,571*

7.

SOLE DISPOSITIVE POWER

 

35,000

8.

SHARED DISPOSITIVE POWER

 

13,917,571*

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

13,952,571*

10.

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

 

(see instructions) ☐

11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

9.9%*

12.

TYPE OF REPORTING PERSON (see instructions)

 

IN, HC

 

 
 

 

Item 1.

 

  (a)

Name of Issuer

Rockley Photonics Holdings Limited (the “Issuer”)

     
  (b)

Address of Issuer’s Principal Executive Offices

3rd Floor, 1 Ashley Road

Altrincham, Cheshire, United Kingdom

 

Item 2.

 

  (a)

Name of Person Filing:

ROC SPV XIX LLC*

ATW Partners Opportunities Management, LLC*

Antonio Ruiz-Gimenez*

Kerry Propper*

     
  (b)

Address of the Principal Office or, if none, residence

17 State Street, Suite 2100

New York, NY 10004

     
  (c)

Citizenship

ROC SPV XIX LLC – Delaware

ATW Partners Opportunities Management, LLC – Delaware

Antonio Ruiz-Gimenez – Spain

Kerry Propper – United States

     
  (d)

Title of Class of Securities

Ordinary Shares, $0.000004026575398 par value per share

     
  (e)

CUSIP Number

G7614L109

 

Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: N/A

 

Item 4. Ownership.

 

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

 

  (a)

Amount beneficially owned:

ROC SPV XIX LLC – 35,551,947*

ATW Partners Opportunities Management, LLC – 36,160,705*

Antonio Ruiz-Gimenez – 36,160,705*

Kerry Propper – 36,195,705*

     
  (b)

Percent of class:

ROC SPV XIX LLC – 8.2%*

ATW Partners Opportunities Management, LLC – 9.9%*

Antonio Ruiz-Gimenez – 9.9%*

Kerry Propper – 9.9%*

 

 
 

 

  (c) Number of shares as to which the person has:
       
    (i)

Sole power to vote or to direct the vote

ROC SPV XIX LLC – 0

ATW Partners Opportunities Management, LLC – 0

Antonio Ruiz-Gimenez – 0

Kerry Propper – 35,000

       
    (ii)

Shared power to vote or to direct the vote

ROC SPV XIX LLC – 11,500,000*

ATW Partners Opportunities Management, LLC – 13,917,571*

Antonio Ruiz-Gimenez –13,917,571*

Kerry Propper – 13,917,571*

       
    (iii)

Sole power to dispose or to direct the disposition of

ROC SPV XIX LLC – 0

ATW Partners Opportunities Management, LLC – 0

Antonio Ruiz-Gimenez – 0

Kerry Propper – 35,000

       
    (iv)

Shared power to dispose or to direct the disposition of

ROC SPV XIX LLC – 11,500,000*

ATW Partners Opportunities Management, LLC – 13,917,571*

Antonio Ruiz-Gimenez – 13,917,571*

Kerry Propper – 13,917,571*

 

Instruction. For computations regarding securities which represent a right to acquire an underlying security see §240.13d-3(d)(1).

 

 

 

* Certain of the ordinary shares (“Shares”) reported herein are held by special purpose vehicles (“SPVs”) managed by ATW Partners Opportunities Management, LLC (the “Adviser”) and certain of the Shares reported herein are held by Kerry Propper directly. Antonio Ruiz-Gimenez and Mr. Propper serve as the managing members of the Adviser.

 

By virtue of the relationships, the Reporting Persons may be deemed to have shared voting and dispositive power with respect to the Shares owned directly by the SPVs. This report shall not be deemed an admission that the Reporting Persons are beneficial owners of the Shares for purposes of Section 13 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of the Reporting Persons disclaims beneficial ownership of the Shares reported herein except to the extent of the Reporting Person’s pecuniary interest therein.

 

As of the date of the event which requires this filing, SPV XIX LLC (“SPV XIX”) has (i) warrants to purchase 11,850,649 Shares at an exercise price of $5.00 per Share (“Warrants”); (ii) $36,500,000 principal amount of Convertible Senior Secured Notes due 2026 (“Notes”), which are convertible into 11,850,649 Shares per the initial conversion price of $3.08 per Share; and (iii) the option to acquire an additional $36,500,000 principal amount of Notes, which option is exercisable for a period of 12 months following the effective date of the registration statement covering the Shares underlying the Notes. Each of (i) through (iii) is subject to certain beneficial ownership limitations. The Warrants are subject to a blocker which prevents SPV XIX from exercising the Warrants to the extent that, upon such exercise, SPV XIX, together with its affiliates, would beneficially own in excess of 9.99% Shares outstanding as a result of the exercise (the “Warrant Blocker”). The Notes are subject to a blocker which prevents SPV XIX from converting the Notes to the extent that, upon such conversion it would cause SPV XIX, together with its affiliates, to beneficially own in excess of 9.90% of the Shares outstanding as a result of the conversion (the “Notes Blocker,” together with the Warrant Blocker, the “Blocker”).

 

Percent of class is based upon a statement in the Issuer’s 10-Q filed on May 12, 2022, that there were 129,005,167 Shares outstanding as of May 5, 2022, plus the approximate total number of Shares that the Reporting Persons have the right to acquire upon conversion of Notes and exercise of Warrants, subject to the Beneficial Ownership Limitations, which amount has been added to the Shares outstanding in accordance with Rule 13d-3(d)(i)(1) under the Act.

 

 
 

 

Item 5. Ownership of Five Percent or Less of a Class.

 

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ☐.

  

Item 6. Ownership of More than Five Percent on Behalf of Another Person.

 

N/A

 

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

 

N/A

 

Item 8. Identification and Classification of Members of the Group.

 

N/A

 

Item 9. Notice of Dissolution of Group.

 

N/A

 

Item 10. Certification.

 

 

 

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

 
 

 

CUSIP No. G7614L109

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Dated: June 23, 2022

 

  ROC SPV XIX LLC
     
  By: /s/ Antonio Ruiz-Gimenez
    Antonio Ruiz-Gimenez, Managing Member
     
  ATW Partners Opportunities Management, LLC
     
  By: /s/ Antonio Ruiz-Gimenez
    Antonio Ruiz-Gimenez, Managing Member
     
  Antonio Ruiz-Gimenez
     
  By: /s/ Antonio Ruiz-Gimenez
    Individually
     
  Kerry Propper
     
  By: /s/ Kerry Propper
    Individually

 

The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative other than an executive officer or general partner of the filing person, evidence of the representative’s authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature.

 

Note. Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See s.240.13d-7 for other parties for whom copies are to be sent.

 

Attention. Intentional misstatements or omissions of fact constitute Federal criminal violations (see 18 U.S.C. 1001).

 

 
 

 

CUSIP No. G7614L109

 

JOINT FILING STATEMENT

PURSUANT TO RULE 13D-1(K)(1)

 

The undersigned hereby consent and agree to the joint filing of Schedule 13G under the Securities Exchange Act of 1934, as amended, with respect to the Ordinary Shares of Rockley Photonics Holdings Limited, together with any or all amendments thereto, when and if required. The parties hereto further consent and agree to file this Joint Filing Statement pursuant to Rule13d-1(k)(1)(iii) as an exhibit to Schedule 13G, thereby incorporating the same into such Schedule13G.

 

This Joint Filing Statement may be terminated by any of the undersigned upon written notice or such lesser period of notice as the undersigned may mutually agree.

 

Dated: June 23, 2022

 

  ROC SPV XIX LLCs
   
  By: /s/ Antonio Ruiz-Gimenez
    Antonio Ruiz-Gimenez, Managing Member
     
  ATW Partners Opportunities Management, LLC
     
  By: /s/ Antonio Ruiz-Gimenez
    Antonio Ruiz-Gimenez, Managing Member
     
  Antonio Ruiz-Gimenez
     
  By: /s/ Antonio Ruiz-Gimenez
    Individually
     
  Kerry Propper
     
  By: /s/ Kerry Propper
    Individually

 

 

 

Get the next $RKLY alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$RKLY

DatePrice TargetRatingAnalyst
8/12/2022$6.00 → $2.00Outperform → Neutral
Robert W. Baird
3/9/2022$20.00 → $10.00Outperform
Northland Capital Markets
3/9/2022$6.00 → $5.00Neutral
B of A Securities
3/9/2022$15.00 → $8.00Buy
Needham
12/22/2021$14.00 → $6.00Buy → Neutral
B of A Securities
9/17/2021$14.00Buy
B of A Securities
9/9/2021$22.00Outperform
Cowen
9/7/2021$15.00Buy
Needham
More analyst ratings

$RKLY
Press Releases

Fastest customizable press release news feed in the world

See more
  • Rockley Photonics Receives 2020 UK R&D Tax Credit and Files 2021 R&D Tax Credit Application

    Rockley Photonics Holdings Limited (NYSE:RKLY) ("Rockley"), a global medical technology company focused on delivering leading edge silicon photonics-based biosensing solutions by targeting a portfolio of biomarkers, today announced that it received 12.9 million pounds sterling ($15.5 million) for its fiscal 2020 R&D tax credit from HMRC, the tax agency of the UK government. The Company filed its fiscal 2021 R&D tax credit application and expects to file its fiscal 2022 R&D tax credit application in 2023. About Rockley Photonics Formed in 2013, Rockley is a global medical technology company focused on delivering leading edge silicon photonics-based biosensing solutions that target a portfo

    $RKLY
    Semiconductors
    Technology
  • Rockley Photonics Announces Receipt of Notice from NYSE of Non-Compliance with Continued Listing Standards

    Rockley Photonics Holdings Limited (NYSE:RKLY) ("Rockley"), a global medical technology company focused on delivering leading edge silicon photonics-based biosensing solutions by targeting a portfolio of biomarkers, today announced that it received a notice from the New York Stock Exchange ("NYSE") on December 9, 2022, indicating that the Company is not in compliance with NYSE's continued listing standards, which require an average market capitalization of not less than $50 million over a 30 trading-day period and stockholders' equity of not less than $50 million. The notice has no immediate impact on the listing of Rockley's common stock on the NYSE, subject to the Company's compliance wit

    $RKLY
    Semiconductors
    Technology
  • Rockley Photonics Announces Promotion of Richard A. (Randy) Meier to Chief Executive Officer

    Rickman to serve as executive chair; Becker promoted to interim chief financial officer Rockley Photonics Holdings Limited (NYSE:RKLY), a global medical technology company focused on delivering leading edge silicon photonics-based biosensing solutions by targeting a portfolio of biomarkers, today announced changes to its senior management team. These changes are intended to position the Company for its next phase of growth. Effective immediately, Richard A. Meier has been appointed president and chief executive officer, and will join the board of directors. Dr. Andrew Rickman has resigned as chief executive officer and will take on the role of executive chairman of Rockley. Chad Becker wi

    $RKLY
    Semiconductors
    Technology

$RKLY
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

See more

$RKLY
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

See more

$RKLY
SEC Filings

See more

$RKLY
Leadership Updates

Live Leadership Updates

See more
  • Rockley Photonics Appoints Healthcare Industry Veteran Richard A. "Randy" Meier President and Chief Financial Officer

    Meier to focus on driving cash-efficient performance and enabling commercial production ramp Rockley Photonics Holdings Limited (NYSE:RKLY) ("Rockley"), a global leader in photonics-based health monitoring and communications solutions, today announced the appointment of Richard A. "Randy" Meier as president and chief financial officer (CFO), effective immediately. Meier will shape Rockley's financial and commercialization strategies, and lead its finance, supply chain, quality, regulatory and compliance functions. An accomplished finance and operations leader with a rich background in healthcare therapeutics and medical devices, Meier joins Rockley from Intersect ENT, a leading global ear

    $RKLY
    Semiconductors
    Technology
  • Rockley Photonics Names Nicolaus Henke to Board of Directors

    Rockley Photonics (NYSE:RKLY), a global leader in photonics-based health monitoring and communications solutions, today announced that it named Nicolaus Henke to its board of directors. Dr. Henke will join the board as an independent director, effective February 16, 2022, and will serve on the Nominating & Corporate Governance Committee. "I am very pleased with the appointment of Nicolaus Henke to our board. He brings a wealth of practical experience which will have an immediate impact on Rockley," said Dr. Andrew Rickman, chairman and chief executive officer of Rockley Photonics. "Throughout his career, Nico has advised top teams in leading health systems, medical device companies and pha

    $RKLY
    Semiconductors
    Technology
  • SpartanNash Announces Board Refreshment; Appoints Three New Independent Directors

    Julien Mininberg, Jaymin Patel and Pamela Puryear, Ph.D., Bring Significant Technology, Distribution, Consumer Brand and Human Resources Expertise Food solutions company SpartanNash (the "Company") (NASDAQ:SPTN) today announced that, following a comprehensive board refreshment process, three new independent directors, Julien Mininberg, Jaymin Patel and Pamela Puryear, Ph.D., have been appointed to the Company's Board of Directors (the "Board"), effective immediately. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220207005303/en/Julien Mininberg (Photo: Business Wire) "Since last summer, our Board has undertaken a deliberate and

    $BALY
    $CLRM
    $HELE
    $NXGN
    Hotels/Resorts
    Consumer Discretionary
    Consumer Electronics/Appliances
    Industrials

$RKLY
Financials

Live finance-specific insights

See more
  • Rockley Photonics Reports Third Quarter of Fiscal 2022 Financial Results

    Additional capital raised through private placement Reduction in headcount and operating costs targets lower cash burn Advanced blood pressure biomarker by demonstrating promising intra-subject tracking against standard blood pressure cuff Rockley Photonics Holdings Limited (NYSE:RKLY), a global medical technology company focused on delivering leading edge silicon photonics-based biosensing solutions by targeting a portfolio of biomarkers, today announced its financial results for the third quarter ended September 30, 2022. During the quarter, the Company advanced its technology platform, Bioptx™, through several technical and clinical targets: Expanded Free-Living Human Study of Its B

    $RKLY
    Semiconductors
    Technology
  • Rockley Photonics Announces Date of Third Quarter 2022 Financial Results Release

    Rockley Photonics (NYSE:RKLY), a global leader in photonics-based health monitoring and communications solutions, today announced that it plans to report its third quarter 2022 financial results after the market closes on Wednesday, November 9, 2022. The company also plans to host a conference call that day at 5:00 p.m. Eastern Time to review its financial results and business outlook. The conference call can be accessed by dialing 877-407-0832 from the United States or +1 201-689-8433 internationally, referencing Rockley Photonics. A live webcast and replay of the conference call can be accessed from the investor relations page on Rockley's website at investors.rockleyphotonics.com. Follo

    $RKLY
    Semiconductors
    Technology
  • Rockley Photonics Reports Second Quarter of Fiscal 2022 Financial Results

    Signs Supply Agreement and Receives First Commercial Purchase Order from Top-Tier Medtech Company for Bioptx™ Baseline Band, Targets Fourth Quarter to Begin Shipping Signs First Contract Research Organization Partnership to Develop and Evaluate Rockley's Bioptx™ Biomarker Sensing Platform for Use in Clinical Trials Bolsters Board of Directors and Establishes Scientific Advisory Board Rockley Photonics Holdings Limited (NYSE:RKLY), a global leader in photonics-based health monitoring and communications solutions, today announced its financial results for the second quarter ended June 30, 2022. "I am proud of the progress we made in the second quarter. As we ramp towards commercial produc

    $RKLY
    Semiconductors
    Technology

$RKLY
Large Ownership Changes

This live feed shows all institutional transactions in real time.

See more